Features Screener Stocks Charts
Sign In Sign Up

Fresenius Kabi Oncology Ltd. Cash Flow Statement

NSE:FKONCO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

1.11x

FKONCO's operating cash flow exceeded net income in FY 2013, indicating earnings are backed by actual cash generation.

Free Cash Flow

₹64.27M

FKONCO's free cash flow was ₹64.27M in FY 2013, down 89.6% from FY 2012.

CapEx Intensity

95.0%

Capital expenditure consumed 95.0% of operating cash flow in FY 2013 for FKONCO, typical of capital-intensive industries.

2-year FKONCO cash flow snapshot

Hover the chart icon for YoY change.

FY 2012 - FY 2013
Item Chart 2012 2013
Net Income 716.96M 1.15B
Cash flow Operating Activities 1.74B 1.27B
Investments in PPE -1.12B -1.21B
Cash flow Investing Activities 168.18M -1.20B
Dividend Paid 0 0
Cash flow Financing Activities 0 0
Cash at beginning of period 184.95M 131.18M
Cash at end of period 0 0
Free Cash Flow 618.66M 64.27M

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2013